Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nevo

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2021
Impact of "critical lesions" on outcomes following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyA Ben-Yaacov, S Laks, M Goldenshluger, et al.
Neurology|July 15, 2011
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyD M Escolar, L P Hache, P R Clemens, et al.
Neurology|March 10, 2012
Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trialD M Escolar, A Zimmerman, T Bertorini, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 5, 2021
Impact of "critical lesions" on outcomes following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyA Ben-Yaacov, S Laks, M Goldenshluger, et al.
Neurology|July 15, 2011
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyD M Escolar, L P Hache, P R Clemens, et al.
Neurology|March 10, 2012
Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trialD M Escolar, A Zimmerman, T Bertorini, et al.
Pageof 6